The benefit of participating to clinical research

Breast Cancer Research and Treatment

Volumn 91, Issue 3, 2005, Pages 279-281

  Hebert Croteau N ^a,b   Brisson, J ^a,c   Lemaire, J ^d   Latreille, J ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b HÔPITAL CHARLES LEMOYNE   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Breast neoplasm; Clinical trials; Outcomes research; Survival

Indexed keywords

BREAST CANCER; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL RESEARCH; CONFERENCE PAPER; CONFIDENCE INTERVAL; DATA ANALYSIS; HEALTH HAZARD; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BIOMEDICAL RESEARCH; BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 21244491594     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-0320-0     Document Type: Conference Paper

References (17)

1. BK Edwards HL Howe LAG Ries MJ Thun HM Rosenberg R Yancik 2002 Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden Cancer 94 2766 2792
2. DP Goldman SH Berry MS McCabe ML Kilgore AL Potosky ML Schoenbaum 2003 Incremental treatment costs in National Cancer Institute-sponsored clinical trials JAMA 289 2970 2977
3. HC Tate JB Rawlinson 1979 Randomized comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet ii 623 625
4. CJ Twelves CS Thomson J Young A Gould 1998 Entry into clinical trials in breast cancer: the importance of specialists teams Eur J Cancer 34 1004 1007
5. RJ Prescott CE Counsell WJ Gillespie AM Grant IT Russell S Kiauka 1999 Factors that limit the quality, number and progress of randomised controlled trials Health Technol Assess 3 1 143
6. CB Begg 1988 Selection of patients for clinical trials Sem Oncol 15 434 440
7. SD Fossa E Skovlund 2002 Selection of patients may limit the generalizability of results from cancer trials Acta Oncol 41 131 137
8. N Bijker JL Peterse IS Fentiman J-P Julien AAM Hart A Avril 2002 Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS Br J Cancer 87 615 620
9. AL Hallstrom L Friedman P Denes C Rizo-Patron M Morris The CAST and AVID investigators 2003 Do arrhythmia patients improve survival by participating in randomized clinical trials? Observations from the Cardiac Arrhythmia Suppression Trial (CAST) and the Antiarrhythmics versus Implantable Defibrillators Trial (AVID) Controlled Clin Trial 24 341 352
10. MC Bahit CP Cannon EM Antman SA Murphy CM Gibson CH McCabe 2003 Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 trail and TIMI 9 registry Am Heart J 145 109 117
11. HD Sesso JM Gaziano M VanDenburgh CH Hennekens RJ Glynn JE Buring 2002 Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomised clinical trial: the Physicians' Health Study Controlled Clin Trial 23 686 702
12. JM Peppercorn JC Weeks EF Cook S Joffe 2004 Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review Lancet 363 263 270
13. N Hébert-Croteau J Brisson J Latreille G Gariépy C Blanchette L Deschênes 1999 Time trends in systemic adjuvant treatment for node-negative breast cancer J Clin Oncol 17 1458 1464
14. Hébert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G: Compliance with consensus recommendations for treatment improves survival of women with node-negative breast cancer. J Clin Oncol 22: 3685-3693, 2004.
15. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chron Dis 40 373 383
16. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 613 619
17. JH Glick RD Gelber A Goldhirsh H-J Senn 1992 Meeting highlights: adjuvant therapy for primary breast cancer J Natl Cancer Inst 84 1479 1485